位置:首页 > 蛋白库 > LAMP2_HUMAN
LAMP2_HUMAN
ID   LAMP2_HUMAN             Reviewed;         410 AA.
AC   P13473; A8K4X5; D3DTF0; Q16641; Q6Q3G8; Q96J30; Q99534; Q9UD93;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 2.
DT   03-AUG-2022, entry version 223.
DE   RecName: Full=Lysosome-associated membrane glycoprotein 2;
DE            Short=LAMP-2;
DE            Short=Lysosome-associated membrane protein 2;
DE   AltName: Full=CD107 antigen-like family member B;
DE   AltName: Full=LGP-96 {ECO:0000303|PubMed:8662539};
DE   AltName: CD_antigen=CD107b;
DE   Flags: Precursor;
GN   Name=LAMP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LAMP-2A), AND PROTEIN SEQUENCE OF
RP   29-64; 216-223 AND 238-256.
RX   PubMed=3198605; DOI=10.1016/s0021-9258(18)37370-8;
RA   Fukuda M., Viitala J., Matteson J., Carlsson S.R.;
RT   "Cloning of cDNAs encoding human lysosomal membrane glycoproteins, h-lamp-1
RT   and h-lamp-2. Comparison of their deduced amino acid sequences.";
RL   J. Biol. Chem. 263:18920-18928(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM LAMP-2A).
RC   TISSUE=Placenta;
RX   PubMed=8517882; DOI=10.1016/s0021-9258(18)52972-0;
RA   Sawada R., Jardine K.A., Fukuda M.;
RT   "The genes of major lysosomal membrane glycoproteins, lamp-1 and lamp-2.
RT   5'-flanking sequence of lamp-2 gene and comparison of exon organization in
RT   two genes.";
RL   J. Biol. Chem. 268:9014-9022(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LAMP-2B).
RC   TISSUE=Fibroblast;
RX   PubMed=8407947; DOI=10.1016/s0021-9258(19)36899-1;
RA   Fritz G., Dosch J., Thielmann H.W., Kaina B.;
RT   "Molecular and cellular characterization of Mex-/methylation-resistant
RT   phenotype. Gene and cDNA cloning, serum dependence, and tumor suppression
RT   of transfectant strains.";
RL   J. Biol. Chem. 268:21102-21112(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LAMP-2A).
RC   TISSUE=Liver;
RX   PubMed=7999007; DOI=10.1006/bbrc.1994.2620;
RA   Konecki D.S., Foetisch K., Schlotter M., Lichter-Konecki U.;
RT   "Complete cDNA sequence of human lysosome-associated membrane protein-2.";
RL   Biochem. Biophys. Res. Commun. 205:1-5(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LAMP-2B), AND TISSUE SPECIFICITY.
RX   PubMed=7488019; DOI=10.1006/bbrc.1995.2528;
RA   Konecki D.S., Foetisch K., Zimmer K.P., Schlotter M., Lichter-Konecki U.;
RT   "An alternatively spliced form of the human lysosome-associated membrane
RT   protein-2 gene is expressed in a tissue-specific manner.";
RL   Biochem. Biophys. Res. Commun. 215:757-767(1995).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LAMP-2C).
RA   Zhou D., Blum J.S.;
RT   "Lamp-2 isoforms play different roles in lysosomal biogenesis.";
RL   Submitted (FEB-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LAMP-2A).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LAMP-2B).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   PROTEIN SEQUENCE OF 29-66, GLYCOSYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=2912382; DOI=10.1016/0003-9861(89)90597-3;
RA   Mane S.M., Marzella L., Bainton D.F., Holt V.K., Cha Y., Hildreth J.E.K.,
RA   August J.T.;
RT   "Purification and characterization of human lysosomal membrane
RT   glycoproteins.";
RL   Arch. Biochem. Biophys. 268:360-378(1989).
RN   [12]
RP   PROTEIN SEQUENCE OF 29-43.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally verified
RT   cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [13]
RP   POLYLACTOSAMINOGLYCANS, AND GLYCOSYLATION.
RX   PubMed=2243102; DOI=10.1016/s0021-9258(17)30530-6;
RA   Carlsson S.R., Fukuda M.;
RT   "The polylactosaminoglycans of human lysosomal membrane glycoproteins lamp-
RT   1 and lamp-2. Localization on the peptide backbones.";
RL   J. Biol. Chem. 265:20488-20495(1990).
RN   [14]
RP   GLYCOSYLATION OF HINGE REGION, AND PROTEIN SEQUENCE OF 187-215.
RX   PubMed=8323299; DOI=10.1006/abbi.1993.1322;
RA   Carlsson S.R., Lycksell P.-O., Fukuda M.;
RT   "Assignment of O-glycan attachment sites to the hinge-like regions of human
RT   lysosomal membrane glycoproteins lamp-1 and lamp-2.";
RL   Arch. Biochem. Biophys. 304:65-73(1993).
RN   [15]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=8662539; DOI=10.1126/science.273.5274.501;
RA   Cuervo A.M., Dice J.F.;
RT   "A receptor for the selective uptake and degradation of proteins by
RT   lysosomes.";
RL   Science 273:501-503(1996).
RN   [16]
RP   FUNCTION (ISOFORM LAMP-2A), SUBCELLULAR LOCATION, TOPOLOGY, AND MUTAGENESIS
RP   OF 401-LYS--HIS-404.
RX   PubMed=11082038; DOI=10.1242/jcs.113.24.4441;
RA   Cuervo A.M., Dice J.F.;
RT   "Unique properties of lamp2a compared to other lamp2 isoforms.";
RL   J. Cell Sci. 113:4441-4450(2000).
RN   [17]
RP   GLYCOSYLATION AT ASN-49 AND ASN-101.
RX   PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [18]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-32; ASN-38; ASN-49; ASN-101;
RP   ASN-123 AND ASN-257.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J.,
RA   Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [19]
RP   NOMENCLATURE.
RX   PubMed=16190986; DOI=10.1111/j.1600-0854.2005.00337.x;
RA   Eskelinen E.L., Cuervo A.M., Taylor M.R., Nishino I., Blum J.S., Dice J.F.,
RA   Sandoval I.V., Lippincott-Schwartz J., August J.T., Saftig P.;
RT   "Unifying nomenclature for the isoforms of the lysosomal membrane protein
RT   LAMP-2.";
RL   Traffic 6:1058-1061(2005).
RN   [20]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Placenta;
RX   PubMed=17897319; DOI=10.1111/j.1600-0854.2007.00643.x;
RA   Schroeder B., Wrocklage C., Pan C., Jaeger R., Koesters B., Schaefer H.,
RA   Elsaesser H.-P., Mann M., Hasilik A.;
RT   "Integral and associated lysosomal membrane proteins.";
RL   Traffic 8:1676-1686(2007).
RN   [21]
RP   FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=18644871; DOI=10.1128/mcb.02070-07;
RA   Bandyopadhyay U., Kaushik S., Varticovski L., Cuervo A.M.;
RT   "The chaperone-mediated autophagy receptor organizes in dynamic protein
RT   complexes at the lysosomal membrane.";
RL   Mol. Cell. Biol. 28:5747-5763(2008).
RN   [22]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-101; ASN-123; ASN-257 AND
RP   ASN-356.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [23]
RP   FUNCTION.
RX   PubMed=20518820; DOI=10.1111/j.1365-2567.2010.03309.x;
RA   Crotzer V.L., Glosson N., Zhou D., Nishino I., Blum J.S.;
RT   "LAMP-2-deficient human B cells exhibit altered MHC class II presentation
RT   of exogenous antigens.";
RL   Immunology 131:318-330(2010).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [25]
RP   INTERACTION WITH ABCB9.
RX   PubMed=22641697; DOI=10.1242/jcs.087346;
RA   Demirel O., Jan I., Wolters D., Blanz J., Saftig P., Tampe R., Abele R.;
RT   "The lysosomal polypeptide transporter TAPL is stabilized by interaction
RT   with LAMP-1 and LAMP-2.";
RL   J. Cell Sci. 125:4230-4240(2012).
RN   [26]
RP   INTERACTION WITH MLLT11, AND FUNCTION.
RX   PubMed=24880125; DOI=10.1016/j.yexcr.2014.05.013;
RA   Li P., Ji M., Lu F., Zhang J., Li H., Cui T., Li Wang X., Tang D., Ji C.;
RT   "Degradation of AF1Q by chaperone-mediated autophagy.";
RL   Exp. Cell Res. 327:48-56(2014).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [28]
RP   FUNCTION.
RX   PubMed=27628032; DOI=10.1242/bio.018648;
RA   Hubert V., Peschel A., Langer B., Groeger M., Rees A., Kain R.;
RT   "LAMP-2 is required for incorporating syntaxin-17 into autophagosomes and
RT   for their fusion with lysosomes.";
RL   Biol. Open 5:1516-1529(2016).
RN   [29]
RP   FUNCTION (ISOFORM LAMP-2C), TISSUE SPECIFICITY, AND INDUCTION BY B CELL
RP   STIMULATION.
RX   PubMed=26856698; DOI=10.4049/jimmunol.1501476;
RA   Perez L., McLetchie S., Gardiner G.J., Deffit S.N., Zhou D., Blum J.S.;
RT   "LAMP-2C inhibits MHC class II presentation of cytoplasmic antigens by
RT   disrupting chaperone-mediated autophagy.";
RL   J. Immunol. 196:2457-2465(2016).
RN   [30]
RP   FUNCTION (MICROBIAL INFECTION), INTERACTION WITH FURIN, AND INTERACTION
RP   WITH MUMPS VIRURS PROTEIN F (MICROBIAL INFECTION).
RX   PubMed=32295904; DOI=10.1128/jvi.00050-20;
RA   Ueo A., Kubota M., Shirogane Y., Ohno S., Hashiguchi T., Yanagi Y.;
RT   "Lysosome-Associated Membrane Proteins Support the Furin-Mediated
RT   Processing of the Mumps Virus Fusion Protein.";
RL   J. Virol. 94:0-0(2020).
RN   [31]
RP   STRUCTURE BY NMR OF 369-410, INTERACTION WITH HSPA8, AND SUBUNIT.
RX   PubMed=25342746; DOI=10.1074/jbc.m114.609446;
RA   Rout A.K., Strub M.P., Piszczek G., Tjandra N.;
RT   "Structure of transmembrane domain of lysosome-associated membrane protein
RT   type 2a (LAMP-2A) reveals key features for substrate specificity in
RT   chaperone-mediated autophagy.";
RL   J. Biol. Chem. 289:35111-35123(2014).
RN   [32]
RP   VARIANT DAND ARG-321.
RX   PubMed=15673802; DOI=10.1056/nejmoa033349;
RA   Arad M., Maron B.J., Gorham J.M., Johnson W.H. Jr., Saul J.P.,
RA   Perez-Atayde A.R., Spirito P., Wright G.B., Kanter R.J., Seidman C.E.,
RA   Seidman J.G.;
RT   "Glycogen storage diseases presenting as hypertrophic cardiomyopathy.";
RL   N. Engl. J. Med. 352:362-372(2005).
RN   [33]
RP   VARIANT DAND ARG-321.
RX   PubMed=15907287; DOI=10.1016/j.nmd.2005.02.008;
RA   Musumeci O., Rodolico C., Nishino I., Di Guardo G., Migliorato A.,
RA   Aguennouz M., Mazzeo A., Messina C., Vita G., Toscano A.;
RT   "Asymptomatic hyperCKemia in a case of Danon disease due to a missense
RT   mutation in Lamp-2 gene.";
RL   Neuromuscul. Disord. 15:409-411(2005).
CC   -!- FUNCTION: Plays an important role in chaperone-mediated autophagy, a
CC       process that mediates lysosomal degradation of proteins in response to
CC       various stresses and as part of the normal turnover of proteins with a
CC       long biological half-live (PubMed:8662539, PubMed:11082038,
CC       PubMed:18644871, PubMed:24880125, PubMed:27628032). Functions by
CC       binding target proteins, such as GAPDH and MLLT11, and targeting them
CC       for lysosomal degradation (PubMed:8662539, PubMed:11082038,
CC       PubMed:18644871, PubMed:24880125). Plays a role in lysosomal protein
CC       degradation in response to starvation (By similarity). Required for the
CC       fusion of autophagosomes with lysosomes during autophagy
CC       (PubMed:27628032). Cells that lack LAMP2 express normal levels of
CC       VAMP8, but fail to accumulate STX17 on autophagosomes, which is the
CC       most likely explanation for the lack of fusion between autophagosomes
CC       and lysosomes (PubMed:27628032). Required for normal degradation of the
CC       contents of autophagosomes (PubMed:27628032). Required for efficient
CC       MHCII-mediated presentation of exogenous antigens via its function in
CC       lysosomal protein degradation; antigenic peptides generated by
CC       proteases in the endosomal/lysosomal compartment are captured by
CC       nascent MHCII subunits (PubMed:20518820). Is not required for efficient
CC       MHCII-mediated presentation of endogenous antigens (PubMed:20518820).
CC       {ECO:0000250|UniProtKB:P17046, ECO:0000269|PubMed:11082038,
CC       ECO:0000269|PubMed:18644871, ECO:0000269|PubMed:20518820,
CC       ECO:0000269|PubMed:24880125, ECO:0000269|PubMed:27628032,
CC       ECO:0000269|PubMed:8662539}.
CC   -!- FUNCTION: [Isoform LAMP-2C]: Modulates chaperone-mediated autophagy.
CC       Decreases presentation of endogenous antigens by MHCII. Does not play a
CC       role in the presentation of exogenous and membrane-derived antigens by
CC       MHCII. {ECO:0000269|PubMed:26856698}.
CC   -!- FUNCTION: (Microbial infection) Supports the FURIN-mediated cleavage of
CC       mumps virus fusion protein F by interacting with both FURIN and the
CC       unprocessed form but not the processed form of the viral protein F.
CC       {ECO:0000269|PubMed:32295904}.
CC   -!- SUBUNIT: Monomer (PubMed:18644871, PubMed:25342746). Homodimer
CC       (PubMed:25342746). Homotrimer (PubMed:25342746). Forms large
CC       homooligomers (PubMed:18644871). Interacts (via its cytoplasmic region)
CC       with HSPA8 (PubMed:25342746). Interacts with HSP90 in the lysosome
CC       lumen; this enhances LAMP2 stability (By similarity). Interacts with
CC       MLLT11 (PubMed:24880125). Interacts with ABCB9 (PubMed:22641697).
CC       Interacts with FURIN (PubMed:32295904). {ECO:0000250|UniProtKB:P17046,
CC       ECO:0000269|PubMed:18644871, ECO:0000269|PubMed:22641697,
CC       ECO:0000269|PubMed:24880125, ECO:0000269|PubMed:25342746,
CC       ECO:0000269|PubMed:32295904}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with mumps virus protein F;
CC       this interaction promotes protein F cleavage by FURIN.
CC       {ECO:0000269|PubMed:32295904}.
CC   -!- INTERACTION:
CC       P13473-2; P45844-6: ABCG1; NbExp=3; IntAct=EBI-21591415, EBI-25873349;
CC       P13473-2; Q7Z5M8-2: ABHD12B; NbExp=3; IntAct=EBI-21591415, EBI-21854797;
CC       P13473-2; Q9Y614: ACTL7B; NbExp=3; IntAct=EBI-21591415, EBI-25835070;
CC       P13473-2; Q6DHV7-2: ADAL; NbExp=3; IntAct=EBI-21591415, EBI-18899653;
CC       P13473-2; Q6UY14-3: ADAMTSL4; NbExp=3; IntAct=EBI-21591415, EBI-10173507;
CC       P13473-2; Q96MA6: AK8; NbExp=3; IntAct=EBI-21591415, EBI-8466265;
CC       P13473-2; Q5T2L2: AKR1C8P; NbExp=3; IntAct=EBI-21591415, EBI-22006248;
CC       P13473-2; Q96Q83-2: ALKBH3; NbExp=3; IntAct=EBI-21591415, EBI-9089544;
CC       P13473-2; Q9Y303-2: AMDHD2; NbExp=3; IntAct=EBI-21591415, EBI-12323557;
CC       P13473-2; Q9NU02: ANKEF1; NbExp=3; IntAct=EBI-21591415, EBI-8464238;
CC       P13473-2; Q6LES2: ANXA4; NbExp=3; IntAct=EBI-21591415, EBI-10250835;
CC       P13473-2; P02647: APOA1; NbExp=3; IntAct=EBI-21591415, EBI-701692;
CC       P13473-2; P02749: APOH; NbExp=3; IntAct=EBI-21591415, EBI-2114682;
CC       P13473-2; P53365: ARFIP2; NbExp=3; IntAct=EBI-21591415, EBI-638194;
CC       P13473-2; Q66PJ3-4: ARL6IP4; NbExp=3; IntAct=EBI-21591415, EBI-5280499;
CC       P13473-2; Q6XD76: ASCL4; NbExp=3; IntAct=EBI-21591415, EBI-10254793;
CC       P13473-2; P18848: ATF4; NbExp=3; IntAct=EBI-21591415, EBI-492498;
CC       P13473-2; Q9H0Y0: ATG10; NbExp=3; IntAct=EBI-21591415, EBI-1048913;
CC       P13473-2; C1IDX9: ATG12; NbExp=3; IntAct=EBI-21591415, EBI-25836940;
CC       P13473-2; O75964: ATP5MG; NbExp=3; IntAct=EBI-21591415, EBI-1044001;
CC       P13473-2; Q14032: BAAT; NbExp=3; IntAct=EBI-21591415, EBI-8994378;
CC       P13473-2; P54687-4: BCAT1; NbExp=3; IntAct=EBI-21591415, EBI-25834445;
CC       P13473-2; P06276: BCHE; NbExp=3; IntAct=EBI-21591415, EBI-7936069;
CC       P13473-2; Q9NSI6-4: BRWD1; NbExp=3; IntAct=EBI-21591415, EBI-10693038;
CC       P13473-2; Q8WZ55: BSND; NbExp=3; IntAct=EBI-21591415, EBI-7996695;
CC       P13473-2; Q96Q07-2: BTBD9; NbExp=3; IntAct=EBI-21591415, EBI-22006737;
CC       P13473-2; Q9H0W9-3: C11orf54; NbExp=3; IntAct=EBI-21591415, EBI-12108466;
CC       P13473-2; Q9NQ89: C12orf4; NbExp=3; IntAct=EBI-21591415, EBI-11090973;
CC       P13473-2; Q13901: C1D; NbExp=3; IntAct=EBI-21591415, EBI-3844053;
CC       P13473-2; Q3SXR2: C3orf36; NbExp=3; IntAct=EBI-21591415, EBI-18036948;
CC       P13473-2; Q8N1A6: C4orf33; NbExp=3; IntAct=EBI-21591415, EBI-10264911;
CC       P13473-2; P17655: CAPN2; NbExp=3; IntAct=EBI-21591415, EBI-1028956;
CC       P13473-2; P20807-4: CAPN3; NbExp=3; IntAct=EBI-21591415, EBI-11532021;
CC       P13473-2; P55212: CASP6; NbExp=3; IntAct=EBI-21591415, EBI-718729;
CC       P13473-2; Q5JTY5: CBWD3; NbExp=3; IntAct=EBI-21591415, EBI-723434;
CC       P13473-2; O00257-3: CBX4; NbExp=3; IntAct=EBI-21591415, EBI-4392727;
CC       P13473-2; P24863: CCNC; NbExp=3; IntAct=EBI-21591415, EBI-395261;
CC       P13473-2; Q9UK58-5: CCNL1; NbExp=3; IntAct=EBI-21591415, EBI-25873837;
CC       P13473-2; Q9NNX6-10: CD209; NbExp=3; IntAct=EBI-21591415, EBI-12300031;
CC       P13473-2; P01730: CD4; NbExp=3; IntAct=EBI-21591415, EBI-353826;
CC       P13473-2; Q9UJX2: CDC23; NbExp=3; IntAct=EBI-21591415, EBI-396137;
CC       P13473-2; P42773: CDKN2C; NbExp=3; IntAct=EBI-21591415, EBI-711290;
CC       P13473-2; O95674: CDS2; NbExp=3; IntAct=EBI-21591415, EBI-3913685;
CC       P13473-2; O15182: CETN3; NbExp=3; IntAct=EBI-21591415, EBI-712959;
CC       P13473-2; Q8WUX9: CHMP7; NbExp=3; IntAct=EBI-21591415, EBI-749253;
CC       P13473-2; Q9Y3D0: CIAO2B; NbExp=3; IntAct=EBI-21591415, EBI-744045;
CC       P13473-2; Q8N365: CIART; NbExp=3; IntAct=EBI-21591415, EBI-10265133;
CC       P13473-2; Q9UHD4: CIDEB; NbExp=3; IntAct=EBI-21591415, EBI-7062247;
CC       P13473-2; Q99966: CITED1; NbExp=3; IntAct=EBI-21591415, EBI-2624951;
CC       P13473-2; P09496-2: CLTA; NbExp=3; IntAct=EBI-21591415, EBI-4401010;
CC       P13473-2; Q6PJW8-3: CNST; NbExp=3; IntAct=EBI-21591415, EBI-25836090;
CC       P13473-2; Q96BR5: COA7; NbExp=3; IntAct=EBI-21591415, EBI-6269632;
CC       P13473-2; P02458-1: COL2A1; NbExp=3; IntAct=EBI-21591415, EBI-12375799;
CC       P13473-2; Q8NI60: COQ8A; NbExp=3; IntAct=EBI-21591415, EBI-745535;
CC       P13473-2; Q9UGL9: CRCT1; NbExp=3; IntAct=EBI-21591415, EBI-713677;
CC       P13473-2; P26998: CRYBB3; NbExp=3; IntAct=EBI-21591415, EBI-1965681;
CC       P13473-2; P35222: CTNNB1; NbExp=3; IntAct=EBI-21591415, EBI-491549;
CC       P13473-2; Q53TN4: CYBRD1; NbExp=3; IntAct=EBI-21591415, EBI-8637742;
CC       P13473-2; P10632: CYP2C8; NbExp=3; IntAct=EBI-21591415, EBI-2951522;
CC       P13473-2; P61962: DCAF7; NbExp=3; IntAct=EBI-21591415, EBI-359808;
CC       P13473-2; Q96LJ7: DHRS1; NbExp=3; IntAct=EBI-21591415, EBI-746300;
CC       P13473-2; O60479: DLX3; NbExp=3; IntAct=EBI-21591415, EBI-3908248;
CC       P13473-2; Q96EY1-3: DNAJA3; NbExp=3; IntAct=EBI-21591415, EBI-11526226;
CC       P13473-2; Q96KC8: DNAJC1; NbExp=3; IntAct=EBI-21591415, EBI-296550;
CC       P13473-2; Q92782-2: DPF1; NbExp=3; IntAct=EBI-21591415, EBI-23669343;
CC       P13473-2; Q9BPU6: DPYSL5; NbExp=3; IntAct=EBI-21591415, EBI-724653;
CC       P13473-2; Q658K8: EEF1DP3; NbExp=3; IntAct=EBI-21591415, EBI-10248874;
CC       P13473-2; O00303: EIF3F; NbExp=3; IntAct=EBI-21591415, EBI-711990;
CC       P13473-2; Q13347: EIF3I; NbExp=3; IntAct=EBI-21591415, EBI-354047;
CC       P13473-2; O00472: ELL2; NbExp=3; IntAct=EBI-21591415, EBI-395274;
CC       P13473-2; O00423: EML1; NbExp=3; IntAct=EBI-21591415, EBI-751327;
CC       P13473-2; O95278-6: EPM2A; NbExp=3; IntAct=EBI-21591415, EBI-25836908;
CC       P13473-2; Q6NXG1-3: ESRP1; NbExp=3; IntAct=EBI-21591415, EBI-21567429;
CC       P13473-2; P00748: F12; NbExp=3; IntAct=EBI-21591415, EBI-6378830;
CC       P13473-2; Q49AJ0-4: FAM135B; NbExp=3; IntAct=EBI-21591415, EBI-25835236;
CC       P13473-2; Q96KS9: FAM167A; NbExp=3; IntAct=EBI-21591415, EBI-10290462;
CC       P13473-2; Q8N128-2: FAM177A1; NbExp=3; IntAct=EBI-21591415, EBI-12201693;
CC       P13473-2; Q8IZU1: FAM9A; NbExp=3; IntAct=EBI-21591415, EBI-8468186;
CC       P13473-2; Q9NYY8: FASTKD2; NbExp=3; IntAct=EBI-21591415, EBI-1055752;
CC       P13473-2; P02671-2: FGA; NbExp=3; IntAct=EBI-21591415, EBI-9640259;
CC       P13473-2; Q6ZNL6: FGD5; NbExp=3; IntAct=EBI-21591415, EBI-7962481;
CC       P13473-2; Q9NSA1: FGF21; NbExp=3; IntAct=EBI-21591415, EBI-3909329;
CC       P13473-2; P49771-3: FLT3LG; NbExp=3; IntAct=EBI-21591415, EBI-25872794;
CC       P13473-2; Q3SYB3: FOXD4L6; NbExp=3; IntAct=EBI-21591415, EBI-6425864;
CC       P13473-2; Q6P7E6: FUT6; NbExp=3; IntAct=EBI-21591415, EBI-25872807;
CC       P13473-2; P06241: FYN; NbExp=3; IntAct=EBI-21591415, EBI-515315;
CC       P13473-2; Q06547-3: GABPB1; NbExp=3; IntAct=EBI-21591415, EBI-9088619;
CC       P13473-2; Q9H3K2: GHITM; NbExp=3; IntAct=EBI-21591415, EBI-2868909;
CC       P13473-2; Q8WWP7: GIMAP1; NbExp=3; IntAct=EBI-21591415, EBI-11991950;
CC       P13473-2; Q49A26-4: GLYR1; NbExp=3; IntAct=EBI-21591415, EBI-12143817;
CC       P13473-2; Q9HAV0: GNB4; NbExp=3; IntAct=EBI-21591415, EBI-358539;
CC       P13473-2; P32780: GTF2H1; NbExp=3; IntAct=EBI-21591415, EBI-715539;
CC       P13473-2; O75409: H2AP; NbExp=3; IntAct=EBI-21591415, EBI-6447217;
CC       P13473-2; Q6NXT2: H3-5; NbExp=3; IntAct=EBI-21591415, EBI-2868501;
CC       P13473-2; P68431: H3C12; NbExp=3; IntAct=EBI-21591415, EBI-79722;
CC       P13473-2; Q9BT25: HAUS8; NbExp=3; IntAct=EBI-21591415, EBI-2558143;
CC       P13473-2; Q9NRZ9-6: HELLS; NbExp=3; IntAct=EBI-21591415, EBI-12003732;
CC       P13473-2; Q96EW2-2: HSPBAP1; NbExp=3; IntAct=EBI-21591415, EBI-25835621;
CC       P13473-2; Q8N6M8-2: IQCF1; NbExp=3; IntAct=EBI-21591415, EBI-21771049;
CC       P13473-2; Q92613: JADE3; NbExp=3; IntAct=EBI-21591415, EBI-10278909;
CC       P13473-2; P0C870: JMJD7; NbExp=3; IntAct=EBI-21591415, EBI-9090173;
CC       P13473-2; Q9UK76: JPT1; NbExp=3; IntAct=EBI-21591415, EBI-720411;
CC       P13473-2; Q8N5Z5: KCTD17; NbExp=3; IntAct=EBI-21591415, EBI-743960;
CC       P13473-2; Q8TBB5-2: KLHDC4; NbExp=3; IntAct=EBI-21591415, EBI-21838933;
CC       P13473-2; Q9UH77: KLHL3; NbExp=3; IntAct=EBI-21591415, EBI-8524663;
CC       P13473-2; Q8N4N3-2: KLHL36; NbExp=3; IntAct=EBI-21591415, EBI-10973851;
CC       P13473-2; Q8N1A0: KRT222; NbExp=3; IntAct=EBI-21591415, EBI-8473062;
CC       P13473-2; Q6DKI2: LGALS9C; NbExp=3; IntAct=EBI-21591415, EBI-9088829;
CC       P13473-2; Q9H2C1: LHX5; NbExp=3; IntAct=EBI-21591415, EBI-25835523;
CC       P13473-2; Q8N0U6: LINC00518; NbExp=3; IntAct=EBI-21591415, EBI-10264791;
CC       P13473-2; Q9Y234: LIPT1; NbExp=3; IntAct=EBI-21591415, EBI-727376;
CC       P13473-2; Q99732: LITAF; NbExp=3; IntAct=EBI-21591415, EBI-725647;
CC       P13473-2; Q1L5Z9: LONRF2; NbExp=3; IntAct=EBI-21591415, EBI-2510853;
CC       P13473-2; Q96JB6: LOXL4; NbExp=3; IntAct=EBI-21591415, EBI-749562;
CC       P13473-2; Q8IYG6: LRRC56; NbExp=3; IntAct=EBI-21591415, EBI-14752528;
CC       P13473-2; Q5VYH9: LY9; NbExp=3; IntAct=EBI-21591415, EBI-25872860;
CC       P13473-2; P0DP58-2: LYNX1; NbExp=3; IntAct=EBI-21591415, EBI-21916939;
CC       P13473-2; P43361: MAGEA8; NbExp=3; IntAct=EBI-21591415, EBI-10182930;
CC       P13473-2; Q96M61: MAGEB18; NbExp=3; IntAct=EBI-21591415, EBI-741835;
CC       P13473-2; Q969L2: MAL2; NbExp=3; IntAct=EBI-21591415, EBI-944295;
CC       P13473-2; P27338: MAOB; NbExp=3; IntAct=EBI-21591415, EBI-3911344;
CC       P13473-2; Q8NI22: MCFD2; NbExp=3; IntAct=EBI-21591415, EBI-2689785;
CC       P13473-2; A6NJ78-4: METTL15; NbExp=3; IntAct=EBI-21591415, EBI-10174029;
CC       P13473-2; A0A0A0MR05: MLST8; NbExp=3; IntAct=EBI-21591415, EBI-25835557;
CC       P13473-2; P34949-2: MPI; NbExp=3; IntAct=EBI-21591415, EBI-21823432;
CC       P13473-2; Q9BV20: MRI1; NbExp=3; IntAct=EBI-21591415, EBI-747381;
CC       P13473-2; Q6IN84-2: MRM1; NbExp=3; IntAct=EBI-21591415, EBI-25835707;
CC       P13473-2; Q8N387: MUC15; NbExp=3; IntAct=EBI-21591415, EBI-17937277;
CC       P13473-2; A2RUH7: MYBPHL; NbExp=3; IntAct=EBI-21591415, EBI-9088235;
CC       P13473-2; P01106: MYC; NbExp=3; IntAct=EBI-21591415, EBI-447544;
CC       P13473-2; Q9H7X0: NAA60; NbExp=3; IntAct=EBI-21591415, EBI-12260336;
CC       P13473-2; Q15742-2: NAB2; NbExp=3; IntAct=EBI-21591415, EBI-25834665;
CC       P13473-2; Q9UJ70-2: NAGK; NbExp=3; IntAct=EBI-21591415, EBI-11526455;
CC       P13473-2; Q69YL0: NCBP2AS2; NbExp=3; IntAct=EBI-21591415, EBI-10986258;
CC       P13473-2; P25208: NFYB; NbExp=3; IntAct=EBI-21591415, EBI-389728;
CC       P13473-2; Q8NDH3-5: NPEPL1; NbExp=3; IntAct=EBI-21591415, EBI-12329915;
CC       P13473-2; O15130-2: NPFF; NbExp=3; IntAct=EBI-21591415, EBI-25840002;
CC       P13473-2; P36639-4: NUDT1; NbExp=3; IntAct=EBI-21591415, EBI-25834643;
CC       P13473-2; Q8NFH4: NUP37; NbExp=3; IntAct=EBI-21591415, EBI-2563158;
CC       P13473-2; Q8NFH3: NUP43; NbExp=3; IntAct=EBI-21591415, EBI-1059321;
CC       P13473-2; Q7Z3B4: NUP54; NbExp=3; IntAct=EBI-21591415, EBI-741048;
CC       P13473-2; Q6N063-2: OGFOD2; NbExp=3; IntAct=EBI-21591415, EBI-22006224;
CC       P13473-2; Q6GQQ9-2: OTUD7B; NbExp=3; IntAct=EBI-21591415, EBI-25830200;
CC       P13473-2; Q99447: PCYT2; NbExp=3; IntAct=EBI-21591415, EBI-750317;
CC       P13473-2; P27815-4: PDE4A; NbExp=3; IntAct=EBI-21591415, EBI-12080840;
CC       P13473-2; A5PLL7: PEDS1; NbExp=3; IntAct=EBI-21591415, EBI-11337896;
CC       P13473-2; Q9BUL5: PHF23; NbExp=3; IntAct=EBI-21591415, EBI-722852;
CC       P13473-2; Q00169: PITPNA; NbExp=3; IntAct=EBI-21591415, EBI-1042490;
CC       P13473-2; P48739: PITPNB; NbExp=3; IntAct=EBI-21591415, EBI-1047143;
CC       P13473-2; Q58EX7-2: PLEKHG4; NbExp=3; IntAct=EBI-21591415, EBI-21503705;
CC       P13473-2; O60664: PLIN3; NbExp=3; IntAct=EBI-21591415, EBI-725795;
CC       P13473-2; Q14181: POLA2; NbExp=3; IntAct=EBI-21591415, EBI-712752;
CC       P13473-2; P0DPB6: POLR1D; NbExp=3; IntAct=EBI-21591415, EBI-359498;
CC       P13473-2; P36954: POLR2I; NbExp=3; IntAct=EBI-21591415, EBI-395202;
CC       P13473-2; Q07869: PPARA; NbExp=3; IntAct=EBI-21591415, EBI-78615;
CC       P13473-2; O60927: PPP1R11; NbExp=3; IntAct=EBI-21591415, EBI-1048104;
CC       P13473-2; Q6ZMI0-5: PPP1R21; NbExp=3; IntAct=EBI-21591415, EBI-25835994;
CC       P13473-2; Q8NCQ7-2: PROCA1; NbExp=3; IntAct=EBI-21591415, EBI-25836043;
CC       P13473-2; P23942: PRPH2; NbExp=3; IntAct=EBI-21591415, EBI-25836834;
CC       P13473-2; P41222: PTGDS; NbExp=3; IntAct=EBI-21591415, EBI-948821;
CC       P13473-2; P29074: PTPN4; NbExp=3; IntAct=EBI-21591415, EBI-710431;
CC       P13473-2; Q8WUD1-2: RAB2B; NbExp=3; IntAct=EBI-21591415, EBI-25835884;
CC       P13473-2; Q5R372-9: RABGAP1L; NbExp=3; IntAct=EBI-21591415, EBI-10699389;
CC       P13473-2; Q9HD47-3: RANGRF; NbExp=3; IntAct=EBI-21591415, EBI-9089733;
CC       P13473-2; Q09028: RBBP4; NbExp=3; IntAct=EBI-21591415, EBI-620823;
CC       P13473-2; Q14498: RBM39; NbExp=3; IntAct=EBI-21591415, EBI-395290;
CC       P13473-2; Q96HR9-2: REEP6; NbExp=3; IntAct=EBI-21591415, EBI-14065960;
CC       P13473-2; Q04206: RELA; NbExp=3; IntAct=EBI-21591415, EBI-73886;
CC       P13473-2; P47804-3: RGR; NbExp=3; IntAct=EBI-21591415, EBI-25834767;
CC       P13473-2; Q15382: RHEB; NbExp=4; IntAct=EBI-21591415, EBI-1055287;
CC       P13473-2; Q9NPQ8-4: RIC8A; NbExp=3; IntAct=EBI-21591415, EBI-9091816;
CC       P13473-2; Q06587: RING1; NbExp=3; IntAct=EBI-21591415, EBI-752313;
CC       P13473-2; Q8N5U6: RNF10; NbExp=3; IntAct=EBI-21591415, EBI-714023;
CC       P13473-2; Q96IZ7: RSRC1; NbExp=3; IntAct=EBI-21591415, EBI-712189;
CC       P13473-2; Q66K80: RUSC1-AS1; NbExp=3; IntAct=EBI-21591415, EBI-10248967;
CC       P13473-2; O15126: SCAMP1; NbExp=3; IntAct=EBI-21591415, EBI-954338;
CC       P13473-2; P22307-3: SCP2; NbExp=3; IntAct=EBI-21591415, EBI-25834804;
CC       P13473-2; Q9BRK5: SDF4; NbExp=3; IntAct=EBI-21591415, EBI-1389808;
CC       P13473-2; Q9NTN9-3: SEMA4G; NbExp=3; IntAct=EBI-21591415, EBI-9089805;
CC       P13473-2; P01011: SERPINA3; NbExp=3; IntAct=EBI-21591415, EBI-296557;
CC       P13473-2; A0A1P0AYU5: SFXN3; NbExp=3; IntAct=EBI-21591415, EBI-14193895;
CC       P13473-2; Q9NR46: SH3GLB2; NbExp=3; IntAct=EBI-21591415, EBI-749607;
CC       P13473-2; Q9BZQ2: SHCBP1L; NbExp=3; IntAct=EBI-21591415, EBI-10818532;
CC       P13473-2; O60902-3: SHOX2; NbExp=3; IntAct=EBI-21591415, EBI-9092164;
CC       P13473-2; O43772: SLC25A20; NbExp=3; IntAct=EBI-21591415, EBI-727085;
CC       P13473-2; Q8IYM2: SLFN12; NbExp=3; IntAct=EBI-21591415, EBI-2822550;
CC       P13473-2; Q86US8: SMG6; NbExp=3; IntAct=EBI-21591415, EBI-3232100;
CC       P13473-2; Q96EX1: SMIM12; NbExp=3; IntAct=EBI-21591415, EBI-2874543;
CC       P13473-2; P37840: SNCA; NbExp=3; IntAct=EBI-21591415, EBI-985879;
CC       P13473-2; Q96H20: SNF8; NbExp=3; IntAct=EBI-21591415, EBI-747719;
CC       P13473-2; Q8N0X7: SPART; NbExp=3; IntAct=EBI-21591415, EBI-2643803;
CC       P13473-2; Q496A3: SPATS1; NbExp=3; IntAct=EBI-21591415, EBI-3923692;
CC       P13473-2; Q9NYA1-2: SPHK1; NbExp=3; IntAct=EBI-21591415, EBI-12512419;
CC       P13473-2; Q9BPZ2: SPIN2B; NbExp=3; IntAct=EBI-21591415, EBI-21726245;
CC       P13473-2; Q9C004: SPRY4; NbExp=3; IntAct=EBI-21591415, EBI-354861;
CC       P13473-2; Q96BD6: SPSB1; NbExp=3; IntAct=EBI-21591415, EBI-2659201;
CC       P13473-2; Q9BXA5: SUCNR1; NbExp=3; IntAct=EBI-21591415, EBI-17962797;
CC       P13473-2; Q92797-2: SYMPK; NbExp=3; IntAct=EBI-21591415, EBI-21560407;
CC       P13473-2; O60506-4: SYNCRIP; NbExp=3; IntAct=EBI-21591415, EBI-11123832;
CC       P13473-2; P08247: SYP; NbExp=3; IntAct=EBI-21591415, EBI-9071725;
CC       P13473-2; Q17RD7: SYT16; NbExp=3; IntAct=EBI-21591415, EBI-10238936;
CC       P13473-2; O95947: TBX6; NbExp=3; IntAct=EBI-21591415, EBI-2824328;
CC       P13473-2; O15273: TCAP; NbExp=3; IntAct=EBI-21591415, EBI-954089;
CC       P13473-2; Q86WV5: TEN1; NbExp=3; IntAct=EBI-21591415, EBI-2562799;
CC       P13473-2; P54274-2: TERF1; NbExp=3; IntAct=EBI-21591415, EBI-711018;
CC       P13473-2; P22735: TGM1; NbExp=3; IntAct=EBI-21591415, EBI-2562368;
CC       P13473-2; O43548: TGM5; NbExp=3; IntAct=EBI-21591415, EBI-12027348;
CC       P13473-2; Q9P2T0: THEG; NbExp=3; IntAct=EBI-21591415, EBI-751020;
CC       P13473-2; Q9NQ88: TIGAR; NbExp=3; IntAct=EBI-21591415, EBI-3920747;
CC       P13473-2; O14925: TIMM23; NbExp=3; IntAct=EBI-21591415, EBI-1047996;
CC       P13473-2; Q12893: TMEM115; NbExp=3; IntAct=EBI-21591415, EBI-8633987;
CC       P13473-2; Q8WVE6-2: TMEM171; NbExp=3; IntAct=EBI-21591415, EBI-25874374;
CC       P13473-2; Q3YBM2: TMEM176B; NbExp=3; IntAct=EBI-21591415, EBI-2821479;
CC       P13473-2; Q53NU3: tmp_locus_54; NbExp=3; IntAct=EBI-21591415, EBI-10242677;
CC       P13473-2; Q9NS69: TOMM22; NbExp=3; IntAct=EBI-21591415, EBI-1047508;
CC       P13473-2; P04637: TP53; NbExp=3; IntAct=EBI-21591415, EBI-366083;
CC       P13473-2; Q12888: TP53BP1; NbExp=3; IntAct=EBI-21591415, EBI-396540;
CC       P13473-2; O00463: TRAF5; NbExp=3; IntAct=EBI-21591415, EBI-523498;
CC       P13473-2; P36406: TRIM23; NbExp=3; IntAct=EBI-21591415, EBI-740098;
CC       P13473-2; Q9C035-3: TRIM5; NbExp=3; IntAct=EBI-21591415, EBI-12840050;
CC       P13473-2; Q86WT6-2: TRIM69; NbExp=3; IntAct=EBI-21591415, EBI-11525489;
CC       P13473-2; Q9H313-4: TTYH1; NbExp=3; IntAct=EBI-21591415, EBI-17671298;
CC       P13473-2; Q9BQE3: TUBA1C; NbExp=3; IntAct=EBI-21591415, EBI-1103245;
CC       P13473-2; P49459: UBE2A; NbExp=3; IntAct=EBI-21591415, EBI-2339348;
CC       P13473-2; P62253: UBE2G1; NbExp=3; IntAct=EBI-21591415, EBI-2340619;
CC       P13473-2; P09936: UCHL1; NbExp=3; IntAct=EBI-21591415, EBI-714860;
CC       P13473-2; Q9P1Q0-4: VPS54; NbExp=3; IntAct=EBI-21591415, EBI-25835297;
CC       P13473-2; Q9NX94: WBP1L; NbExp=3; IntAct=EBI-21591415, EBI-10316321;
CC       P13473-2; Q6ICG8: WBP2NL; NbExp=3; IntAct=EBI-21591415, EBI-17769315;
CC       P13473-2; Q8NA23-2: WDR31; NbExp=3; IntAct=EBI-21591415, EBI-25835937;
CC       P13473-2; Q9BQA1: WDR77; NbExp=3; IntAct=EBI-21591415, EBI-1237307;
CC       P13473-2; O00755: WNT7A; NbExp=3; IntAct=EBI-21591415, EBI-727198;
CC       P13473-2; O95070: YIF1A; NbExp=3; IntAct=EBI-21591415, EBI-2799703;
CC       P13473-2; Q8IWT0-2: ZBTB8OS; NbExp=3; IntAct=EBI-21591415, EBI-12956041;
CC       P13473-2; Q53FD0-2: ZC2HC1C; NbExp=3; IntAct=EBI-21591415, EBI-14104088;
CC       P13473-2; Q05CR2: ZNF248; NbExp=3; IntAct=EBI-21591415, EBI-25835471;
CC       P13473-2; Q96JL9-2: ZNF333; NbExp=3; IntAct=EBI-21591415, EBI-25835852;
CC       P13473-2; Q96LX8: ZNF597; NbExp=3; IntAct=EBI-21591415, EBI-9091553;
CC       P13473-2; Q3KNS6-3: ZNF829; NbExp=3; IntAct=EBI-21591415, EBI-18036029;
CC       P13473-2; A0A384MDV8; NbExp=3; IntAct=EBI-21591415, EBI-25834468;
CC       P13473-2; B7Z3E8; NbExp=3; IntAct=EBI-21591415, EBI-25831617;
CC       P13473-2; Q86V28; NbExp=3; IntAct=EBI-21591415, EBI-10259496;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:17897319,
CC       ECO:0000269|PubMed:2912382}; Single-pass type I membrane protein
CC       {ECO:0000255|PROSITE-ProRule:PRU00740, ECO:0000269|PubMed:17897319}.
CC       Endosome membrane {ECO:0000269|PubMed:17897319}; Single-pass type I
CC       membrane protein {ECO:0000255|PROSITE-ProRule:PRU00740,
CC       ECO:0000269|PubMed:17897319}. Lysosome membrane {ECO:0000255|PROSITE-
CC       ProRule:PRU00740, ECO:0000269|PubMed:11082038,
CC       ECO:0000269|PubMed:17897319, ECO:0000269|PubMed:18644871,
CC       ECO:0000269|PubMed:2912382}; Single-pass type I membrane protein
CC       {ECO:0000255|PROSITE-ProRule:PRU00740, ECO:0000269|PubMed:17897319}.
CC       Cytoplasmic vesicle, autophagosome membrane
CC       {ECO:0000250|UniProtKB:P17047}. Note=This protein shuttles between
CC       lysosomes, endosomes, and the plasma membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=LAMP-2A;
CC         IsoId=P13473-1; Sequence=Displayed;
CC       Name=LAMP-2B;
CC         IsoId=P13473-2; Sequence=VSP_003044;
CC       Name=LAMP-2C;
CC         IsoId=P13473-3; Sequence=VSP_042519;
CC   -!- TISSUE SPECIFICITY: Isoform LAMP-2A is highly expressed in placenta,
CC       lung and liver, less in kidney and pancreas, low in brain and skeletal
CC       muscle (PubMed:7488019, PubMed:26856698). Isoform LAMP-2B is detected
CC       in spleen, thymus, prostate, testis, small intestine, colon, skeletal
CC       muscle, brain, placenta, lung, kidney, ovary and pancreas and liver
CC       (PubMed:7488019, PubMed:26856698). Isoform LAMP-2C is detected in small
CC       intestine, colon, heart, brain, skeletal muscle, and at lower levels in
CC       kidney and placenta (PubMed:26856698). {ECO:0000269|PubMed:26856698,
CC       ECO:0000269|PubMed:7488019}.
CC   -!- INDUCTION: In peripheral blood B cells isoform LAMP-2A, LAMP-2B and
CC       LAMP-2C are up-regulated in response to treatments that stimulate
CC       immune responses via the Toll-like receptors TLR7 or TLR9.
CC       {ECO:0000269|PubMed:26856698}.
CC   -!- PTM: O- and N-glycosylated; some of the 16 N-linked glycans are
CC       polylactosaminoglycans. {ECO:0000269|PubMed:12754519,
CC       ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:19159218,
CC       ECO:0000269|PubMed:2243102, ECO:0000269|PubMed:2912382,
CC       ECO:0000269|PubMed:8323299}.
CC   -!- DISEASE: Danon disease (DAND) [MIM:300257]: DAND is a lysosomal
CC       glycogen storage disease characterized by the clinical triad of
CC       cardiomyopathy, vacuolar myopathy and intellectual disability. It is
CC       often associated with an accumulation of glycogen in muscle and
CC       lysosomes. {ECO:0000269|PubMed:15673802, ECO:0000269|PubMed:15907287}.
CC       Note=The disease is caused by variants affecting the gene represented
CC       in this entry.
CC   -!- SIMILARITY: Belongs to the LAMP family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00740}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J04183; AAA60383.1; -; mRNA.
DR   EMBL; L09717; AAB41647.1; -; Genomic_DNA.
DR   EMBL; L09709; AAB41647.1; JOINED; Genomic_DNA.
DR   EMBL; L09710; AAB41647.1; JOINED; Genomic_DNA.
DR   EMBL; L09711; AAB41647.1; JOINED; Genomic_DNA.
DR   EMBL; L09712; AAB41647.1; JOINED; Genomic_DNA.
DR   EMBL; L09713; AAB41647.1; JOINED; Genomic_DNA.
DR   EMBL; L09714; AAB41647.1; JOINED; Genomic_DNA.
DR   EMBL; L09715; AAB41647.1; JOINED; Genomic_DNA.
DR   EMBL; L09716; AAB41647.1; JOINED; Genomic_DNA.
DR   EMBL; X77196; CAA54416.1; -; mRNA.
DR   EMBL; S79873; AAB35426.1; -; mRNA.
DR   EMBL; U36336; AAA91149.1; -; mRNA.
DR   EMBL; AY561849; AAS67876.1; -; mRNA.
DR   EMBL; AK291090; BAF83779.1; -; mRNA.
DR   EMBL; AC002476; AAB67313.1; -; Genomic_DNA.
DR   EMBL; AC002476; AAB67314.1; -; Genomic_DNA.
DR   EMBL; CH471107; EAX11881.1; -; Genomic_DNA.
DR   EMBL; CH471107; EAX11882.1; -; Genomic_DNA.
DR   EMBL; CH471107; EAX11883.1; -; Genomic_DNA.
DR   EMBL; CH471107; EAX11884.1; -; Genomic_DNA.
DR   EMBL; BC002965; AAH02965.1; -; mRNA.
DR   CCDS; CCDS14599.1; -. [P13473-1]
DR   CCDS; CCDS14600.1; -. [P13473-2]
DR   CCDS; CCDS48159.1; -. [P13473-3]
DR   PIR; JC2414; B31959.
DR   PIR; JC4317; JC4317.
DR   RefSeq; NP_001116078.1; NM_001122606.1. [P13473-3]
DR   RefSeq; NP_002285.1; NM_002294.2. [P13473-1]
DR   RefSeq; NP_054701.1; NM_013995.2. [P13473-2]
DR   PDB; 2MOF; NMR; -; A=369-410.
DR   PDB; 2MOM; NMR; -; A/B/C=369-410.
DR   PDBsum; 2MOF; -.
DR   PDBsum; 2MOM; -.
DR   AlphaFoldDB; P13473; -.
DR   BMRB; P13473; -.
DR   SMR; P13473; -.
DR   BioGRID; 110114; 609.
DR   IntAct; P13473; 304.
DR   MINT; P13473; -.
DR   STRING; 9606.ENSP00000408411; -.
DR   TCDB; 9.A.16.1.2; the lysosomal protein import (lpi) family.
DR   GlyConnect; 356; 115 N-Linked glycans (12 sites), 3 O-Linked glycans.
DR   GlyGen; P13473; 27 sites, 145 N-linked glycans (12 sites), 6 O-linked glycans (10 sites).
DR   iPTMnet; P13473; -.
DR   PhosphoSitePlus; P13473; -.
DR   SwissPalm; P13473; -.
DR   BioMuta; LAMP2; -.
DR   DMDM; 1708854; -.
DR   CPTAC; CPTAC-1494; -.
DR   CPTAC; CPTAC-689; -.
DR   EPD; P13473; -.
DR   jPOST; P13473; -.
DR   MassIVE; P13473; -.
DR   MaxQB; P13473; -.
DR   PeptideAtlas; P13473; -.
DR   PRIDE; P13473; -.
DR   ProteomicsDB; 52910; -. [P13473-1]
DR   ProteomicsDB; 52911; -. [P13473-2]
DR   ProteomicsDB; 52912; -. [P13473-3]
DR   Antibodypedia; 3938; 1317 antibodies from 52 providers.
DR   DNASU; 3920; -.
DR   Ensembl; ENST00000200639.9; ENSP00000200639.4; ENSG00000005893.16. [P13473-1]
DR   Ensembl; ENST00000371335.4; ENSP00000360386.4; ENSG00000005893.16. [P13473-2]
DR   Ensembl; ENST00000434600.6; ENSP00000408411.2; ENSG00000005893.16. [P13473-3]
DR   GeneID; 3920; -.
DR   KEGG; hsa:3920; -.
DR   MANE-Select; ENST00000200639.9; ENSP00000200639.4; NM_002294.3; NP_002285.1.
DR   UCSC; uc004ess.5; human. [P13473-1]
DR   CTD; 3920; -.
DR   DisGeNET; 3920; -.
DR   GeneCards; LAMP2; -.
DR   GeneReviews; LAMP2; -.
DR   HGNC; HGNC:6501; LAMP2.
DR   HPA; ENSG00000005893; Low tissue specificity.
DR   MalaCards; LAMP2; -.
DR   MIM; 300257; phenotype.
DR   MIM; 309060; gene.
DR   neXtProt; NX_P13473; -.
DR   OpenTargets; ENSG00000005893; -.
DR   Orphanet; 34587; Glycogen storage disease due to LAMP-2 deficiency.
DR   PharmGKB; PA30285; -.
DR   VEuPathDB; HostDB:ENSG00000005893; -.
DR   eggNOG; KOG4818; Eukaryota.
DR   GeneTree; ENSGT00950000182899; -.
DR   HOGENOM; CLU_055379_2_0_1; -.
DR   InParanoid; P13473; -.
DR   OMA; NMATGYE; -.
DR   OrthoDB; 1042920at2759; -.
DR   PhylomeDB; P13473; -.
DR   TreeFam; TF316339; -.
DR   PathwayCommons; P13473; -.
DR   Reactome; R-HSA-114608; Platelet degranulation.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-9613829; Chaperone Mediated Autophagy.
DR   SignaLink; P13473; -.
DR   SIGNOR; P13473; -.
DR   BioGRID-ORCS; 3920; 10 hits in 707 CRISPR screens.
DR   ChiTaRS; LAMP2; human.
DR   GeneWiki; LAMP2; -.
DR   GenomeRNAi; 3920; -.
DR   Pharos; P13473; Tbio.
DR   PRO; PR:P13473; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; P13473; protein.
DR   Bgee; ENSG00000005893; Expressed in corpus callosum and 206 other tissues.
DR   ExpressionAtlas; P13473; baseline and differential.
DR   Genevisible; P13473; HS.
DR   GO; GO:0044754; C:autolysosome; IDA:MGI.
DR   GO; GO:0035577; C:azurophil granule membrane; TAS:Reactome.
DR   GO; GO:0061742; C:chaperone-mediated autophagy translocation complex; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0101003; C:ficolin-1-rich granule membrane; TAS:Reactome.
DR   GO; GO:0097637; C:integral component of autophagosome membrane; IBA:GO_Central.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005770; C:late endosome; IDA:MGI.
DR   GO; GO:0031902; C:late endosome membrane; IDA:MGI.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:MGI.
DR   GO; GO:0005764; C:lysosome; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0031088; C:platelet dense granule membrane; IDA:MGI.
DR   GO; GO:0005802; C:trans-Golgi network; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0097352; P:autophagosome maturation; ISS:UniProtKB.
DR   GO; GO:0009267; P:cellular response to starvation; ISS:UniProtKB.
DR   GO; GO:0061684; P:chaperone-mediated autophagy; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0072594; P:establishment of protein localization to organelle; IBA:GO_Central.
DR   GO; GO:1905146; P:lysosomal protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0046716; P:muscle cell cellular homeostasis; IEA:Ensembl.
DR   GO; GO:0031333; P:negative regulation of protein-containing complex assembly; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0017038; P:protein import; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0050821; P:protein stabilization; ISS:CAFA.
DR   GO; GO:0006605; P:protein targeting; ISS:UniProtKB.
DR   GO; GO:0061740; P:protein targeting to lysosome involved in chaperone-mediated autophagy; IMP:UniProtKB.
DR   GO; GO:0031647; P:regulation of protein stability; IMP:ParkinsonsUK-UCL.
DR   InterPro; IPR018134; LAMP_CS.
DR   InterPro; IPR002000; Lysosome-assoc_membr_glycop.
DR   PANTHER; PTHR11506; PTHR11506; 1.
DR   Pfam; PF01299; Lamp; 1.
DR   PRINTS; PR00336; LYSASSOCTDMP.
DR   PROSITE; PS00310; LAMP_1; 1.
DR   PROSITE; PS00311; LAMP_2; 1.
DR   PROSITE; PS51407; LAMP_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Autophagy; Cell membrane;
KW   Cytoplasmic vesicle; Direct protein sequencing; Disease variant;
KW   Disulfide bond; Endosome; Glycogen storage disease; Glycoprotein; Lysosome;
KW   Membrane; Reference proteome; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..28
FT                   /evidence="ECO:0000269|PubMed:15340161,
FT                   ECO:0000269|PubMed:2912382, ECO:0000269|PubMed:3198605"
FT   CHAIN           29..410
FT                   /note="Lysosome-associated membrane glycoprotein 2"
FT                   /id="PRO_0000017110"
FT   TOPO_DOM        29..375
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        376..399
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00740"
FT   TOPO_DOM        400..410
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00740"
FT   REGION          29..192
FT                   /note="First lumenal domain"
FT   REGION          193..228
FT                   /note="Hinge"
FT   REGION          199..221
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          229..375
FT                   /note="Second lumenal domain"
FT   REGION          401..404
FT                   /note="Important for binding and subsequent lysosomal
FT                   degradation of target proteins"
FT                   /evidence="ECO:0000269|PubMed:11082038"
FT   CARBOHYD        32
FT                   /note="N-linked (GlcNAc...) (polylactosaminoglycan)
FT                   asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952"
FT   CARBOHYD        38
FT                   /note="N-linked (GlcNAc...) (polylactosaminoglycan)
FT                   asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952"
FT   CARBOHYD        49
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:12754519,
FT                   ECO:0000269|PubMed:16335952"
FT   CARBOHYD        58
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:8323299"
FT   CARBOHYD        75
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:8323299"
FT   CARBOHYD        101
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:12754519,
FT                   ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:19159218"
FT   CARBOHYD        123
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952,
FT                   ECO:0000269|PubMed:19159218"
FT   CARBOHYD        179
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:8323299"
FT   CARBOHYD        195
FT                   /note="O-linked (GalNAc...) serine"
FT                   /evidence="ECO:0000269|PubMed:8323299"
FT   CARBOHYD        196
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000269|PubMed:8323299"
FT   CARBOHYD        200
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000269|PubMed:8323299"
FT   CARBOHYD        203
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000269|PubMed:8323299"
FT   CARBOHYD        204
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000269|PubMed:8323299"
FT   CARBOHYD        207
FT                   /note="O-linked (GalNAc...) serine; partial"
FT                   /evidence="ECO:0000269|PubMed:8323299"
FT   CARBOHYD        209
FT                   /note="O-linked (GalNAc...) threonine; partial"
FT                   /evidence="ECO:0000269|PubMed:8323299"
FT   CARBOHYD        210
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000269|PubMed:8323299"
FT   CARBOHYD        211
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000269|PubMed:8323299"
FT   CARBOHYD        213
FT                   /note="O-linked (GalNAc...) threonine; partial"
FT                   /evidence="ECO:0000269|PubMed:8323299"
FT   CARBOHYD        229
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:8323299"
FT   CARBOHYD        242
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:8323299"
FT   CARBOHYD        257
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952,
FT                   ECO:0000269|PubMed:19159218"
FT   CARBOHYD        275
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:8323299"
FT   CARBOHYD        300
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:8323299"
FT   CARBOHYD        307
FT                   /note="N-linked (GlcNAc...) (polylactosaminoglycan)
FT                   asparagine"
FT                   /evidence="ECO:0000269|PubMed:8323299"
FT   CARBOHYD        317
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:8323299"
FT   CARBOHYD        356
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   DISULFID        41..79
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00740"
FT   DISULFID        153..189
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00740"
FT   DISULFID        232..265
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00740"
FT   DISULFID        331..368
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00740"
FT   VAR_SEQ         366..410
FT                   /note="QDCSADDDNFLVPIAVGAALAGVLILVLLAYFIGLKHHHAGYEQF -> EEC
FT                   SADSDLNFLIPVAVGVALGFLIIVVFISYMIGRRKSRTGYQSV (in isoform
FT                   LAMP-2C)"
FT                   /evidence="ECO:0000303|Ref.6"
FT                   /id="VSP_042519"
FT   VAR_SEQ         367..410
FT                   /note="DCSADDDNFLVPIAVGAALAGVLILVLLAYFIGLKHHHAGYEQF -> ECSL
FT                   DDDTILIPIIVGAGLSGLIIVIVIAYVIGRRKSYAGYQTL (in isoform LAMP-
FT                   2B)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:7488019, ECO:0000303|PubMed:8407947"
FT                   /id="VSP_003044"
FT   VARIANT         256
FT                   /note="P -> H (in dbSNP:rs1043878)"
FT                   /id="VAR_011992"
FT   VARIANT         321
FT                   /note="W -> R (in DAND; dbSNP:rs104894859)"
FT                   /evidence="ECO:0000269|PubMed:15673802,
FT                   ECO:0000269|PubMed:15907287"
FT                   /id="VAR_026230"
FT   MUTAGEN         401..404
FT                   /note="KHHH->AAAA: Impairs binding and subsequent lysosomal
FT                   degradation of target proteins, such as GAPDH."
FT                   /evidence="ECO:0000269|PubMed:11082038"
FT   CONFLICT        8..13
FT                   /note="PVPGSG -> RFRSGLR (in Ref. 3; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        53
FT                   /note="R -> G (in Ref. 3; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        68
FT                   /note="D -> V (in Ref. 2; AAB41647)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        111
FT                   /note="I -> N (in Ref. 2; AAB41647)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        143
FT                   /note="I -> Y (in Ref. 2; AAB41647)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        220
FT                   /note="A -> P (in Ref. 2; AAB41647)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        234
FT                   /note="L -> R (in Ref. 2; AAB41647)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        263..269
FT                   /note="GSCRSHT -> AAAVSH (in Ref. 3; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        322..326
FT                   /note="DAPLG -> MPP (in Ref. 1; AAA60383)"
FT                   /evidence="ECO:0000305"
FT   STRAND          374..377
FT                   /evidence="ECO:0007829|PDB:2MOF"
FT   HELIX           380..400
FT                   /evidence="ECO:0007829|PDB:2MOF"
SQ   SEQUENCE   410 AA;  44961 MW;  9E08E3B62D58F454 CRC64;
     MVCFRLFPVP GSGLVLVCLV LGAVRSYALE LNLTDSENAT CLYAKWQMNF TVRYETTNKT
     YKTVTISDHG TVTYNGSICG DDQNGPKIAV QFGPGFSWIA NFTKAASTYS IDSVSFSYNT
     GDNTTFPDAE DKGILTVDEL LAIRIPLNDL FRCNSLSTLE KNDVVQHYWD VLVQAFVQNG
     TVSTNEFLCD KDKTSTVAPT IHTTVPSPTT TPTPKEKPEA GTYSVNNGND TCLLATMGLQ
     LNITQDKVAS VININPNTTH STGSCRSHTA LLRLNSSTIK YLDFVFAVKN ENRFYLKEVN
     ISMYLVNGSV FSIANNNLSY WDAPLGSSYM CNKEQTVSVS GAFQINTFDL RVQPFNVTQG
     KYSTAQDCSA DDDNFLVPIA VGAALAGVLI LVLLAYFIGL KHHHAGYEQF
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024